Header Logo

Connection

Yasu Morita to Mutation

This is a "connection" page, showing publications Yasu Morita has written about Mutation.
Connection Strength

0.145
  1. Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K. ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. Int J Hematol. 2022 Nov; 116(5):659-668.
    View in: PubMed
    Score: 0.106
  2. Nakatani F, Morita YS, Ashida H, Nagamune K, Maeda Y, Kinoshita T. Identification of a second catalytically active trans-sialidase in Trypanosoma brucei. Biochem Biophys Res Commun. 2011 Nov 18; 415(2):421-5.
    View in: PubMed
    Score: 0.013
  3. Crellin PK, Kovacevic S, Martin KL, Brammananth R, Morita YS, Billman-Jacobe H, McConville MJ, Coppel RL. Mutations in pimE restore lipoarabinomannan synthesis and growth in a Mycobacterium smegmatis lpqW mutant. J Bacteriol. 2008 May; 190(10):3690-9.
    View in: PubMed
    Score: 0.010
  4. Kovacevic S, Anderson D, Morita YS, Patterson J, Haites R, McMillan BN, Coppel R, McConville MJ, Billman-Jacobe H. Identification of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria. J Biol Chem. 2006 Apr 07; 281(14):9011-7.
    View in: PubMed
    Score: 0.008
  5. Hong Y, Nagamune K, Ohishi K, Morita YS, Ashida H, Maeda Y, Kinoshita T. TbGPI16 is an essential component of GPI transamidase in Trypanosoma brucei. FEBS Lett. 2006 Jan 23; 580(2):603-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.